Feeling worse during the first few weeks on an antidepressant is common, and there’s a biological reason for it. The medication changes your brain chemistry almost immediately, but the therapeutic benefits take weeks to develop. That gap between “drug is active” and “drug is helping” is when most people experience increased anxiety, nausea, sleep disruption, or a temporary dip in mood. About 15% of people experience a noticeable worsening of anxiety in the first two weeks alone.
Why the Drug Works Against You Before It Works for You
Most commonly prescribed antidepressants, particularly SSRIs, work by blocking the reabsorption of serotonin so more of it stays available between nerve cells. This happens within hours of your first dose. But your brain has a built-in thermostat: sensors on serotonin-producing neurons detect the sudden surplus and respond by dialing down the firing rate of those neurons. Less firing means less serotonin gets released in the first place, which undermines the whole point of the medication.
Over the course of several weeks, those sensors gradually lose their sensitivity. As they desensitize, the neurons start firing normally again, and the drug can finally do its job of keeping more serotonin active. This desensitization process typically takes two to four weeks, which lines up closely with when most people begin noticing improvement. During that lag, you’re dealing with the side effects of altered brain chemistry without the mood benefits.
The Brain Changes That Take Weeks to Build
Serotonin adjustment is only part of the story. Antidepressants also trigger slower, structural changes in the brain. One of the most important involves a growth factor called BDNF, which supports the health and connectivity of neurons, particularly in regions tied to mood and memory. Antidepressant drugs increase BDNF expression on a timeline that mirrors when patients start feeling better: not hours, but weeks.
Think of it this way. The immediate chemical shift is like flipping a switch, but the wiring behind the switch needs to be repaired before the light actually turns on. The drug changes the chemical environment quickly, and then downstream processes, like new neural connections and restored signaling pathways, gradually catch up. That mismatch between fast chemistry and slow repair is a core reason the first weeks feel rough.
Increased Anxiety and Agitation
One of the most unsettling early effects is a spike in anxiety or restlessness. This is sometimes called jitteriness syndrome, and it’s driven by the same serotonin surge that will eventually help you. Before your brain adjusts, the excess serotonin activates certain receptors that can trigger agitation, nervousness, and a feeling of being wired. In clinical studies, this tends to emerge within the first two weeks of treatment.
In one study of over 200 people starting SSRIs for depression, about 15% experienced a measurable worsening of anxiety symptoms by week two. Nearly half showed improvement in anxiety over that same period, and about a third stayed roughly the same. So while the odds favor either stability or improvement, the possibility of feeling more anxious is real and not a sign the medication is wrong for you.
Why Your Stomach Reacts Too
Nausea, diarrhea, and stomach discomfort rank among the most common early complaints. This makes sense when you consider that 95% of the serotonin in your body is produced in the gut, not the brain. Serotonin is the primary chemical messenger that enteric neurons use to regulate gut motility, the rhythmic contractions that move food through your digestive system. When an SSRI floods the gut with extra serotonin, it disrupts that regulation, leading to nausea, loose stools, or sometimes constipation.
These digestive side effects generally ease as your body adjusts. Most people find them manageable within the first one to two weeks, and taking the medication with food or at a different time of day can help reduce their intensity.
Suicidal Thoughts in Young People
The FDA requires a boxed warning on all antidepressants about an increased risk of suicidal thinking and behavior in children and adolescents. This warning came from a combined analysis of short-term trials (up to four months) across nine antidepressant drugs. The risk of suicidal thoughts or behavior was 4% among those taking the medication, compared to 2% on placebo. No suicides occurred in any of these trials.
This risk appears concentrated in the early weeks of treatment, which aligns with the same period when the medication’s side effects are strongest but its therapeutic effects haven’t kicked in. For adults, the data is less clear, but heightened monitoring during the first month is standard practice regardless of age. If you notice new thoughts of self-harm, or feel markedly more agitated or impulsive, that warrants an immediate conversation with your prescriber.
How Starting Low Helps
The most common strategy for reducing early side effects is starting at a lower dose than the target and increasing gradually. This “start low, go slow” approach gives your brain and gut time to adjust to rising serotonin levels without the full shock of a therapeutic dose on day one. Many prescribers will begin at half the intended dose for the first week or two before stepping up.
In some cases, particularly when anxiety is severe, a short-term anti-anxiety medication may be prescribed alongside the antidepressant during the startup phase. These are used temporarily to blunt the initial agitation and jitteriness while the antidepressant reaches its full effect. There’s evidence this approach can improve adherence by helping people push through the difficult first weeks rather than abandoning treatment. However, these bridging medications carry their own risks, including dependency, so they’re not used routinely.
Telling Startup Effects From a Bad Fit
The hardest question during those early weeks is whether what you’re feeling is a temporary adjustment or a sign that this particular drug isn’t right for you. A few patterns help distinguish the two.
Startup side effects tend to be physical (nausea, headaches, sleep changes, jitteriness) and begin within days of starting the medication. They generally stabilize or improve by weeks two to three. A deepening of depression or the emergence of new psychiatric symptoms like agitation, impulsivity, or hypomanic behavior (racing thoughts, decreased need for sleep, unusual energy) is more concerning and worth reporting promptly.
The early treatment window, roughly the first six weeks, can occasionally produce paradoxical reactions where the depression itself temporarily worsens. If your mood continues to decline beyond that window, or if new symptoms appear that feel qualitatively different from your baseline depression, the medication may not be working as intended. The key distinction is trajectory: startup effects get better with time, while a poor medication match either stays flat or trends downward.
Keeping a simple daily log of your mood, sleep, appetite, and any new symptoms gives both you and your prescriber concrete data to work with at follow-up visits, rather than relying on memory of how the past few weeks felt.